Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 82

    1.

    Self-monitoring of blood glucose (SMBG) in patients with type 2 diabetes on oral anti-diabetes drugs: cost-effectiveness in France, Germany, Italy, and Spain.

    Tunis SL, Willis WD, Foos V.

    Curr Med Res Opin. 2009 Nov 18. [Epub ahead of print]PMID: 19919377 [PubMed - as supplied by publisher]Related articles

    3.

    A Cost-Effectiveness Analysis to Illustrate the Impact of Cost Definitions on Results, Interpretations and Comparability of Pharmacoeconomic Studies in the US.

    Tunis SL.

    Pharmacoeconomics. 2009;27(9):735-44. doi: 10.2165/10899600-000000000-00000.PMID: 19757867 [PubMed - in process]Related articles

    4.

    Comparative effectiveness research in Ontario, Canada: producing relevant and timely information for health care decision makers.

    Whicher DM, Chalkidou K, Dhalla IA, Levin L, Tunis S.

    Milbank Q. 2009 Sep;87(3):585-606.PMID: 19751283 [PubMed - indexed for MEDLINE]Related articles

    5.

    Comparative effectiveness research priorities: identifying critical gaps in evidence for clinical and health policy decision making.

    Chalkidou K, Whicher D, Kary W, Tunis S.

    Int J Technol Assess Health Care. 2009 Jul;25(3):241-8.PMID: 19619341 [PubMed - indexed for MEDLINE]Related articles

    6.

    Rethinking randomized clinical trials for comparative effectiveness research: the need for transformational change.

    Luce BR, Kramer JM, Goodman SN, Connor JT, Tunis S, Whicher D, Schwartz JS.

    Ann Intern Med. 2009 Aug 4;151(3):206-9. Epub 2009 Jun 30. No abstract available. PMID: 19567619 [PubMed - indexed for MEDLINE]Related articles

    7.

    Comparative effectiveness research and evidence-based health policy: experience from four countries.

    Chalkidou K, Tunis S, Lopert R, Rochaix L, Sawicki PT, Nasser M, Xerri B.

    Milbank Q. 2009 Jun;87(2):339-67.PMID: 19523121 [PubMed - indexed for MEDLINE]Related articles

    8.

    Does comparative-effectiveness research threaten personalized medicine?

    Garber AM, Tunis SR.

    N Engl J Med. 2009 May 7;360(19):1925-7. No abstract available. PMID: 19420360 [PubMed - indexed for MEDLINE]Related articles

    9.

    A cost-effectiveness analysis of pioglitazone plus metformin compared with rosiglitazone plus metformin from a third-party payer perspective in the US *

    Charles MS, Minshall ME, Pandya BJ, Baran RW, Tunis SL.

    Curr Med Res Opin. 2009 May 6. [Epub ahead of print]PMID: 19419339 [PubMed - as supplied by publisher]Related articles

    10.

    The National Oncologic PET Registry: lessons learned for coverage with evidence development.

    Tunis S, Whicher D.

    J Am Coll Radiol. 2009 May;6(5):360-5.PMID: 19394577 [PubMed - indexed for MEDLINE]Related articles

    11.

    Health economic comparison between continuous subcutaneous insulin infusion and multiple daily injections of insulin for the treatment of adult type 1 diabetes in Canada.

    St Charles ME, Sadri H, Minshall ME, Tunis SL.

    Clin Ther. 2009 Mar;31(3):657-67.PMID: 19393856 [PubMed - indexed for MEDLINE]Related articles

    12.

    A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers.

    Thorpe KE, Zwarenstein M, Oxman AD, Treweek S, Furberg CD, Altman DG, Tunis S, Bergel E, Harvey I, Magid DJ, Chalkidou K.

    CMAJ. 2009 May 12;180(10):E47-57. Epub 2009 Apr 16. No abstract available. PMID: 19372436 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Cost-effectiveness of insulin detemir compared to NPH insulin for type 1 and type 2 diabetes mellitus in the Canadian payer setting: modeling analysis.

    Tunis SL, Minshall ME, Conner C, McCormick JI, Kapor J, Yale JF, Groleau D.

    Curr Med Res Opin. 2009 May;25(5):1273-84.PMID: 19366302 [PubMed - indexed for MEDLINE]Related articles

    14.

    A new era for cardiovascular imaging? Implications of the revoked national coverage decision for CT angiography on future imaging reimbursement.

    Douglas PS, Budoff M, Tunis S, Woodard PK, Justman RA, Honigberg R.

    JACC Cardiovasc Imaging. 2008 May;1(3):398-403. No abstract available. PMID: 19356455 [PubMed - indexed for MEDLINE]Related articles

    15.

    A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers.

    Thorpe KE, Zwarenstein M, Oxman AD, Treweek S, Furberg CD, Altman DG, Tunis S, Bergel E, Harvey I, Magid DJ, Chalkidou K.

    J Clin Epidemiol. 2009 May;62(5):464-75.PMID: 19348971 [PubMed - indexed for MEDLINE]Related articles

    16.

    Toward a 21st-century health care system: recommendations for health care reform.

    Arrow K, Auerbach A, Bertko J, Brownlee S, Casalino LP, Cooper J, Crosson FJ, Enthoven A, Falcone E, Feldman RC, Fuchs VR, Garber AM, Gold MR, Goldman D, Hadfield GK, Hall MA, Horwitz RI, Hooven M, Jacobson PD, Jost TS, Kotlikoff LJ, Levin J, Levine S, Levy R, Linscott K, Luft HS, Mashal R, McFadden D, Mechanic D, Meltzer D, Newhouse JP, Noll RG, Pietzsch JB, Pizzo P, Reischauer RD, Rosenbaum S, Sage W, Schaeffer LD, Sheen E, Silber BM, Skinner J, Shortell SM, Thier SO, Tunis S, Wulsin L Jr, Yock P, Nun GB, Bryan S, Luxenburg O, van de Ven WP.

    Ann Intern Med. 2009 Apr 7;150(7):493-5. Epub 2009 Mar 2.PMID: 19258550 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Direct medical costs for type 2 diabetes mellitus complications in the US commercial payer setting: a resource for economic research.

    Pelletier EM, Smith PJ, Boye KS, Misurski DA, Tunis SL, Minshall ME.

    Appl Health Econ Health Policy. 2008;6(2-3):103-12. doi: 10.2165/00148365-200806020-00003.PMID: 19231904 [PubMed - indexed for MEDLINE]Related articles

    18.

    Roundtable on expanding capacity for comparative effectiveness research in the United States: discussion took place on June 3, 2007, at the AcademyHealth Annual Research Meetingin Orlando, FL.

    Tunis S, Clancy C, Helms WD, McGinnis JM, Pearson SD.

    Health Serv Res. 2009 Apr;44(2 Pt 1):327-42. Epub 2009 Feb 4. No abstract available. PMID: 19208090 [PubMed - indexed for MEDLINE]Related articles

    19.

    Improving the reporting of pragmatic trials: an extension of the CONSORT statement.

    Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis S, Haynes B, Oxman AD, Moher D; CONSORT group; Pragmatic Trials in Healthcare (Practihc) group.

    BMJ. 2008 Nov 11;337:a2390. doi: 10.1136/bmj.a2390.PMID: 19001484 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Pioglitazone versus rosiglitazone treatment in patients with type 2 diabetes and dyslipidemia: cost-effectiveness in the US.

    Tunis SL, Minshall ME, Charles MS, Pandya BJ, Baran RW.

    Curr Med Res Opin. 2008 Sep 29. [Epub ahead of print]PMID: 18826750 [PubMed - as supplied by publisher]Related articles

    21.

    Crossroads in quality.

    O'Kane M, Corrigan J, Foote SM, Tunis SR, Isham GJ, Nichols LM, Fisher ES, Ebeler JC, Block JA, Bradley BE, Cassel CK, Ness DL, Tooker J.

    Health Aff (Millwood). 2008 May-Jun;27(3):749-58.PMID: 18474968 [PubMed - indexed for MEDLINE]Related articles

    23.

    Self-monitoring of blood glucose in type 2 diabetes: cost-effectiveness in the united states.

    Tunis SL, Minshall ME.

    Am J Manag Care. 2008 Mar;14(3):131-40.PMID: 18333705 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Challenges in Australian policy processes for disinvestment from existing, ineffective health care practices.

    Elshaug AG, Hiller JE, Tunis SR, Moss JR.

    Aust New Zealand Health Policy. 2007 Oct 31;4:23.PMID: 17973993 [PubMed - in process]Related articlesFree article

    25.

    Coverage with evidence development: a very good beginning, but much to be done. Commentary to Hutton et al.

    Tunis SR, Chalkidou K.

    Int J Technol Assess Health Care. 2007 Fall;23(4):432-5. No abstract available. PMID: 17937830 [PubMed - indexed for MEDLINE]Related articles

    26.

    The ethics of using quality improvement methods in health care.

    Lynn J, Baily MA, Bottrell M, Jennings B, Levine RJ, Davidoff F, Casarett D, Corrigan J, Fox E, Wynia MK, Agich GJ, O'Kane M, Speroff T, Schyve P, Batalden P, Tunis S, Berlinger N, Cronenwett L, Fitzmaurice JM, Dubler NN, James B.

    Ann Intern Med. 2007 May 1;146(9):666-73. Epub 2007 Apr 16.PMID: 17438310 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    The National Oncologic PET Registry: expanded medicare coverage for PET under coverage with evidence development.

    Lindsay MJ, Siegel BA, Tunis SR, Hillner BE, Shields AF, Carey BP, Coleman RE.

    AJR Am J Roentgenol. 2007 Apr;188(4):1109-13.PMID: 17377055 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Federal initiatives to support rapid learning about new technologies.

    Tunis SR, Carino TV, Williams RD 2nd, Bach PB.

    Health Aff (Millwood). 2007 Mar-Apr;26(2):w140-9. Epub 2007 Jan 26. Review.PMID: 17259196 [PubMed - indexed for MEDLINE]Related articles

    29.

    An examination of factors affecting persistence with initial antipsychotic treatment in patients with schizophrenia.

    Tunis SL, Faries DE, Stensland MD, Hay DP, Kinon BJ.

    Curr Med Res Opin. 2007 Jan;23(1):97-104.PMID: 17257471 [PubMed - indexed for MEDLINE]Related articles

    30.

    Antipsychotic treatment discontinuation among individuals with schizophrenia and co-occurring substance use.

    Smelson DA, Tunis SL, Nyhuis AW, Faries DE, Kinon BJ, Ascher-Svanum H.

    J Clin Psychopharmacol. 2006 Dec;26(6):666-7. No abstract available. PMID: 17110828 [PubMed - indexed for MEDLINE]Related articles

    31.

    Coverage options for promising technologies: Medicare's 'coverage with evidence development'.

    Tunis SR, Pearson SD.

    Health Aff (Millwood). 2006 Sep-Oct;25(5):1218-30.PMID: 16966717 [PubMed - indexed for MEDLINE]Related articles

    32.

    Cost-effectiveness of olanzapine as first-line treatment for schizophrenia: results from a randomized, open-label, 1-year trial.

    Tunis SL, Faries DE, Nyhuis AW, Kinon BJ, Ascher-Svanum H, Aquila R.

    Value Health. 2006 Mar-Apr;9(2):77-89.PMID: 16626411 [PubMed - indexed for MEDLINE]Related articles

    33.

    Designing naturalistic prospective studies of economic and effectiveness outcomes associated with novel antipsychotic therapies.

    Tunis SL, Johnstone BM, Kinon BJ, Barber BL, Browne RA.

    Value Health. 2000 May-Jun;3(3):232-42. Review.PMID: 16464187 [PubMed - indexed for MEDLINE]Related articles

    34.

    Using clinical trials as a condition of coverage: lessons from the National Emphysema Treatment Trial.

    Carino T, Sheingold S, Tunis S.

    Clin Trials. 2004 Feb;1(1):108-14; discussion 115-21.PMID: 16281466 [PubMed - indexed for MEDLINE]Related articles

    35.

    Promoting informed choice: transforming health care to dispense knowledge for decision making.

    Woolf SH, Chan EC, Harris R, Sheridan SL, Braddock CH 3rd, Kaplan RM, Krist A, O'Connor AM, Tunis S.

    Ann Intern Med. 2005 Aug 16;143(4):293-300.PMID: 16103473 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Service utilization and costs of olanzapine versus divalproex treatment for acute mania: results from a randomized, 47-week clinical trial.

    Zhu B, Tunis SL, Zhao Z, Baker RW, Lage MJ, Shi L, Tohen M.

    Curr Med Res Opin. 2005 Apr;21(4):555-64.PMID: 15899104 [PubMed - indexed for MEDLINE]Related articles

    37.

    Controlled trial of interventions to increase testing and treatment for Helicobacter pylori and reduce medication use in patients with chronic acid-related symptoms.

    Majumdar SR, Ross-Degnan D, Farraye FA, Lee M, Kemp JA, Lecates RF, Henning JM, Tunis SR, Schrammel P, Soumerai SB.

    Aliment Pharmacol Ther. 2005 Apr 15;21(8):1029-39.PMID: 15813839 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Medicare coverage of ICDs.

    McClellan MB, Tunis SR.

    N Engl J Med. 2005 Jan 20;352(3):222-4. No abstract available. PMID: 15659721 [PubMed - indexed for MEDLINE]Related articles

    39.

    A clinical research strategy to support shared decision making.

    Tunis SR.

    Health Aff (Millwood). 2005 Jan-Feb;24(1):180-4.PMID: 15647229 [PubMed - indexed for MEDLINE]Related articles

    40.

    Cognitive and clinical predictors of success in vocational rehabilitation in schizophrenia.

    Evans JD, Bond GR, Meyer PS, Kim HW, Lysaker PH, Gibson PJ, Tunis S.

    Schizophr Res. 2004 Oct 1;70(2-3):331-42.PMID: 15329308 [PubMed - indexed for MEDLINE]Related articles

    41.

    Economic analysis in healthcare decisions.

    Tunis SR.

    Am J Manag Care. 2004 May;10(5):301-4. No abstract available. PMID: 15152698 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Why Medicare has not established criteria for coverage decisions.

    Tunis SR.

    N Engl J Med. 2004 May 20;350(21):2196-8. No abstract available. PMID: 15152066 [PubMed - indexed for MEDLINE]Related articles

    43.

    Clinical use of medical devices in the 'Bermuda Triangle'.

    Kessler L, Ramsey SD, Tunis S, Sullivan SD.

    Health Aff (Millwood). 2004 Jan-Feb;23(1):200-7.PMID: 15002643 [PubMed - indexed for MEDLINE]Related articles

    44.

    Economic outcomes associated with switching individuals with schizophrenia between risperidone and olanzapine: findings from a large US claims database.

    Zhao Z, Namjoshi M, Barber BL, Loosbrock DL, Tunis SL, Zhu B, Breier A.

    CNS Drugs. 2004;18(3):157-64.PMID: 14871159 [PubMed - indexed for MEDLINE]Related articles

    45.

    Assessing the value of antipsychotics for treating schizophrenia: the importance of evaluating and interpreting the clinical significance of individual service costs.

    Tunis SL, Ascher-Svanum H, Stensland M, Kinon BJ.

    Pharmacoeconomics. 2004;22(1):1-8. Review.PMID: 14720078 [PubMed - indexed for MEDLINE]Related articles

    46.

    Response to vocational rehabilitation during treatment with first- or second-generation antipsychotics.

    Bond GR, Kim HW, Meyer PS, Gibson PJ, Tunis S, Evans JD, Lysaker P, McCoy ML, Dincin J, Xie H.

    Psychiatr Serv. 2004 Jan;55(1):59-66.PMID: 14699202 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy.

    Tunis SR, Stryer DB, Clancy CM.

    JAMA. 2003 Sep 24;290(12):1624-32.PMID: 14506122 [PubMed - indexed for MEDLINE]Related articles

    48.

    Characterizing behavioral and psychological symptoms of dementia (BPSD) among geropsychiatric inpatients.

    Tunis SL, Edell WS, Adams BE, Kennedy JS.

    J Am Med Dir Assoc. 2002 May-Jun;3(3):146-51.PMID: 12807658 [PubMed]Related articles

    49.

    Assessing antipsychotic effectiveness in dementia with the factor structure of the Psychogeriatric Dependency Rating Scale (PGDRS).

    Adams BE, Tunis SL, Edell WS.

    J Am Med Dir Assoc. 2003 Mar-Apr;4(2):61-6.PMID: 12807576 [PubMed - indexed for MEDLINE]Related articles

    50.

    Comparison between the effects of atypical and traditional antipsychotics on work status for clients in a psychiatric rehabilitation program.

    Meyer PS, Bond GR, Tunis SL, McCoy ML.

    J Clin Psychiatry. 2002 Feb;63(2):108-16.PMID: 11874210 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...